You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., March 25, 2015 – Astellas, a leading pharmaceutical company based in Northbrook, Ill., has been named one of America’s Best Employers in the biotechnology industry by Forbes...
Read more about Astellas Named One of America’s Best Employers in 2015 by Forbes Magazine
NORTHBROOK, Ill. and SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN)...
NORTHBROOK, Ill., March 6, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of CRESEMBA®...
Funding will support measles vaccination campaigns in Latin America Washington, D.C. March 5, 2015 – The United Nations Foundation’s Shot@Life Campaign, which helps expand access to...
Astellas is Exclusive Health Sponsor of the 'Ticket2Health' Initiative Promoting a Game Plan for Better Health and Wellness NORTHBROOK, Ill., Feb. 20, 2015 /PRNewswire/ -- Astellas Pharma US,...
NORTHBROOK, Ill., Feb. 19, 2015 /PRNewswire/ -- Astellas announces organizational and personnel changes in the Americas, highlighting the Company's focus on international markets, while also...
NORTHBROOK, Ill., Feb. 13, 2015 /PRNewswire/ -- Astellas Pharma Inc. (hereafter called Astellas or "the Company") President and CEO, Yoshihiko Hatanaka, announces the newest element of its...
NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration's (FDA) Anti-infective Drugs Advisory Committee voted unanimously to recommend...
NORTHBROOK, Ill., Dec. 18, 2014 /PRNewswire/ -- Astellas US LLC today announced that the Company's global President and CEO Yoshihiko Hatanaka will present at the 33rd Annual J.P. Morgan...
Read more about Astellas to Present at J.P. Morgan Healthcare Conference
NORTHBROOK, Ill., Nov. 3, 2014 /PRNewswire/ -- Astellas announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to isavuconazole for the treatment of...
Follow U.S. news
